Funder
Eberhard Karls Universität Tübingen
German Research Foundation
Reference42 articles.
1. The antibody aducanumab reduces Abeta plaques in Alzheimer's disease;Sevigny;Nature,2016
2. Lecanemab in Early Alzheimer's Disease;van Dyck;N. Engl. J. Med.,2023
3. Alzheimer's disease: the amyloid cascade hypothesis;Hardy;Science (1979),1992
4. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections;Braak;Brain Pathol.,1991
5. Nelissen N., Laere K.V., Thurfjell L., Owenius R., Vandenbulcke M., Koole M., et al. Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease. 2009;50(8):1251–9.